These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 26261202)

  • 1. Reply to Messori.
    Rein DB
    Clin Infect Dis; 2015 Dec; 61(12):1892-3. PubMed ID: 26261202
    [No Abstract]   [Full Text] [Related]  

  • 2. Newest Treatments for Hepatitis C: How Can We Manage Sustainability?
    Messori A
    Clin Infect Dis; 2015 Dec; 61(12):1891-2. PubMed ID: 26261204
    [No Abstract]   [Full Text] [Related]  

  • 3. [Costs of modern treatment of chronic hepatitis C].
    Stiefelhagen P; Sarrazin C
    Med Monatsschr Pharm; 2015 Sep; 38(9):347-9. PubMed ID: 26731852
    [No Abstract]   [Full Text] [Related]  

  • 4. 'HepConomics': cost-effective, indeed, but how can we pay for it?
    Athanasakis K; Petrakis I; Kyriopoulos J
    J Viral Hepat; 2015 Aug; 22(8):682. PubMed ID: 25727161
    [No Abstract]   [Full Text] [Related]  

  • 5. Combination therapy in naive patients with chronic hepatitis C: more value for the money.
    Koff RS
    J Hepatol; 2000 Oct; 33(4):664-6. PubMed ID: 11059875
    [No Abstract]   [Full Text] [Related]  

  • 6. [Economic evaluation of combined therapy in chronic hepatitis C].
    Casado MA; Buti M; Fosbrook L; Esteban R
    Gastroenterol Hepatol; 2000 Feb; 23 Suppl 1():57-62. PubMed ID: 11968346
    [No Abstract]   [Full Text] [Related]  

  • 7. Editorial commentary: getting smart in how we pay for HCV drugs: KAOS vs CONTROL.
    Saag MS
    Clin Infect Dis; 2015 Jul; 61(2):169-70. PubMed ID: 25778748
    [No Abstract]   [Full Text] [Related]  

  • 8. Only just the beginning of the end of hepatitis C.
    Lancet; 2014 Jan; 383(9914):281. PubMed ID: 24461110
    [No Abstract]   [Full Text] [Related]  

  • 9. Cost-effectiveness of treatment for chronic hepatitis C infection.
    Bernstein D
    JAMA; 2003 Oct; 290(15):1993; author reply 1994. PubMed ID: 14559948
    [No Abstract]   [Full Text] [Related]  

  • 10. Cost-effectiveness of treatment for chronic hepatitis C infection.
    Dore GJ; Thein HH
    JAMA; 2003 Oct; 290(15):1993; author reply 1994. PubMed ID: 14559947
    [No Abstract]   [Full Text] [Related]  

  • 11. Cost-effectiveness of interferon treatment for hepatitis C.
    van Leeuwen DJ
    JAMA; 1999 Jun; 281(22):2083-4. PubMed ID: 10367810
    [No Abstract]   [Full Text] [Related]  

  • 12. Hepatitis C: global ambition, national realities.
    Lancet; 2016 May; 387(10032):1970. PubMed ID: 27203752
    [No Abstract]   [Full Text] [Related]  

  • 13. What price for a cure?
    Taylor LE
    R I Med J (2013); 2014 Jul; 97(7):16-8. PubMed ID: 25184174
    [No Abstract]   [Full Text] [Related]  

  • 14. Does patient cost sharing for HCV drugs make sense?
    Lakdawalla DN; Linthicum MT; Vanderpuye-Orgle J
    Am J Manag Care; 2016 May; 22(6 Spec No.):SP188-90. PubMed ID: 27266947
    [No Abstract]   [Full Text] [Related]  

  • 15. [Not Available].
    Stingl W
    MMW Fortschr Med; 2015 Jun; 157 Suppl 2():55. PubMed ID: 26048126
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment strategy for hepatitis C: a dilemma for the payers and the providers.
    Haque M; Zariat A
    Am J Gastroenterol; 2014 Dec; 109(12):1953-4. PubMed ID: 25470586
    [No Abstract]   [Full Text] [Related]  

  • 17. Effectiveness, costs weigh on HCV treatment decisions.
    Traynor K
    Am J Health Syst Pharm; 2014 Jul; 71(14):1156-7. PubMed ID: 24973370
    [No Abstract]   [Full Text] [Related]  

  • 18. Cost-effectiveness of interferon alfa 2b and ribavirin in the treatment of chronic hepatitis C.
    Kim WR; Poterucha JJ; Gross JB
    Hepatology; 2000 Mar; 31(3):807-8. PubMed ID: 10722315
    [No Abstract]   [Full Text] [Related]  

  • 19. [Cost-effectiveness of antiviral therapy for chronic hepatitis C patients in prevention of hepatocellular cancer ].
    Yoshida H; Tateishi R; Omata M
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):511-4. PubMed ID: 15359852
    [No Abstract]   [Full Text] [Related]  

  • 20. Cost-effectiveness of interferon treatment for hepatitis C.
    Henley E
    JAMA; 1999 Jun; 281(22):2083; author reply 2084. PubMed ID: 10367809
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.